Alexion Pharmaceuticals' Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Alexion Pharmaceuticals careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Position Summary The Business Analysis team, which is a part of the Global Business Development Division, helps control the financial analysis, valuation, and structure of Alexion’s external pipeline investing activities. The team is a hi...
Posted: August 22, 2018, 3:29 am
Position Summary As a single point of contact for compute in Information Technology this role involves developing and maintaining a systems roadmap for infrastructure systems. This individual should have vast experience in des...
Posted: August 21, 2018, 4:48 am
Position Summary The Associate Medical Director will support the Medical Director in providing strategic planning and leadership to all in-country Medical Affairs activities for Alexion’s neurology franchise, specficially for a marketed ...
Posted: August 21, 2018, 4:48 am
Position Summary The Associate Director, Safety Scientist plays a pivotal role within Global Pharmacovigilance to ensure safety assessment for all Alexion products, in close collaboration with the product assigned Global Medical Safety Le...
Posted: August 21, 2018, 4:48 am
Position Summary The Director of Data Standards, Integration and Innovation is accountable for the development and oversight of the digital technology roadmap to define a strategy for integrating clinical data and associated metadata suc...
Posted: August 20, 2018, 11:44 am

Viewing page 1 of 27|Next Page

  Newsfeed | Subscribe  

Wagner as senior vice president, government affairs and policy. Ms. Wagner joins GBT from Alexion Pharmaceuticals, where she was senior vice president, global government affairs. At GBT, Ms. Wagner wi...
Posted: August 21, 2018, 6:13 pm
The Food and Drug Administration has accepted for priority review Alexion Pharmaceuticals’ new drug for a rare blood disorder. The New Haven, Connecticut-based company said Monday that the FDA would r...
Posted: August 21, 2018, 10:07 am
Alexion Pharmaceuticals, Inc. ALXN announced that the FDA has granted a priority review to its biologics license application (BLA) for C5 complement inhibitor, ALXN1210, pertaining to the treatment of ...
Posted: August 21, 2018, 9:21 am
(RTTNews) - Today's Daily Dose brings you news about Amneal Pharma's contract with Jerome Stevens; Alexion Pharma's regulatory catalyst in February 2019; FDA's expanded approval for Merck's Keytruda; ...
Posted: August 21, 2018, 12:16 am
BOSTON–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s Biologics License Application ...
Posted: August 20, 2018, 10:36 am

Viewing page 1 of 3|Next Page